Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 18 to 80

Using Valacyclovir to Manage Pain from Acute Apical Abscesses

Official title: Role of Herpesviruses as a Causative Factor in Acute Apical Abscess

Run by University of California, San Francisco · NCT05266040 · Data updated 2026-11-12

This study tests if adding valacyclovir to antibiotics can help reduce pain for people with acute apical abscesses.

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment60 (estimated)
SponsorUniversity of California, San Francisco
Academic / other
Locations1 site (San Francisco, California)
StatusRecruiting
StartedOctober 25, 2023
Main results expectedDecember 31, 2025
Study endsDecember 31, 2025
Registry record updatedMay 30, 2025
Trial IDNCT05266040 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older who are systemically healthy and exhibit signs of pulp necrosis with moderate to severe pain.

Probably not a fit

Patients with certain dental conditions, smokers, or those with allergies to the study medications may not benefit from this trial.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to evaluate the effectiveness of a treatment regimen combining valacyclovir and antibiotics for managing pain associated with acute apical abscesses. It will involve 250 participants who will be randomly assigned to receive either the combination treatment or antibiotics alone. Preoperative and postoperative imaging will be conducted using cone beam computed tomography (CBCT) to assess pain levels and healing outcomes. The study seeks to address the viral component of endodontic infections to improve patient outcomes.

Why it matters

Potential benefit: If successful, this treatment could significantly reduce pain and accelerate healing for patients suffering from acute apical abscesses.

How similar studies have gone: While this approach is innovative, it builds on preliminary findings from a pilot study, indicating potential for success but is not yet widely tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient must be ≥ 18-year-old
* Patient must be systemically healthy; American Society of Anesthesiologists (ASA) Class I or II
* Patient must exhibit clinical evidence of pulp necrosis and acute apical abscess
* Patient must present with radiographic
* signs of apical disease either by
* periapical radiography or cone-beam
* computed tomography
* Patient consented to receive conventional pulpal debridement, incision and drainage at the end of the study
* Persistent pain of moderate or higher level (\>4) was the main inclusion criterion. Pain assessed as follows: 0 defined as no pain, 1-3 as mild pain, 4-6 as moderate pain, and 7-10 as severe pain

Exclusion Criteria:

* Smokers (more than 10 cigarettes per day)
* External or internal tooth resorption
* Marginal periodontitis
* Pregnant or nursing mothers (hormonal factors may influence the periapical condition)
* Documented allergic or adverse reactions to amoxicillin or valacyclovir
* Teeth with unusual anatomy or inaccurate clinical diagnosis on the day of treatment (i.e., partially necrotic pulp)
* Patients currently taking antibiotics or antiviral medications

Where it's running

  • UCSF Dental
    San Francisco, California, United States
    Recruiting

Study contacts

  • Principal investigator: Mike Sabeti, DDS — University of California, San Francisco
  • Study coordinator: Mike Sabeti, DDS
  • Email: Mike.Sabeti@ucsf.edu
  • Phone: 415-476-0822

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.